导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 8.07% | 144/350 |
| 近一周 | -2.19% | 166/358 |
| 近一月 | -4.77% | 240/358 |
| 近一季 | -2.89% | 156/358 |
| 近半年 | 3.39% | 190/354 |
| 近一年 | 5.92% | 175/345 |
| 近两年 | 1.54% | 288/310 |
| 近三年 | 20.65% | 165/242 |
| 成立以来 | 32.97% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.31% 41/360 |
9.58% 138/366 |
- - |
- - |
| 2025 | -0.18% 311/358 |
0.73% 177/340 |
-2.15% 272/348 |
3.58% 318/354 |
-2.22% 193/358 |
| 2024 | 5.49% 210/329 |
-0.69% 177/280 |
-0.27% 199/310 |
10.97% 123/318 |
-4.02% 229/329 |
| 2023 | 12.98% 75/275 |
0.70% 146/205 |
7.59% 74/230 |
-8.17% 216/262 |
13.54% 31/276 |
| 2022 | -19.41% 89/201 |
-4.17% 24/153 |
-13.09% 111/164 |
-5.19% 71/189 |
2.05% 151/202 |
| 2021 | 36.99% 10/150 |
9.53% 30/312 |
8.84% 81/328 |
1.18% 41/358 |
13.57% 8/151 |
| 2020 | -17.70% 80/103 |
-26.07% 234/280 |
8.42% 183/295 |
-3.48% 251/299 |
6.38% 187/305 |
| 2019 | 20.44% 45/88 |
11.71% 91/258 |
2.27% 108/268 |
8.73% 8/253 |
-3.04% 251/266 |
| 2018 | -1.94% 25/79 |
- - |
- - |
- - |
-6.49% 79/241 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 南方恒生生物科技ETF(QDII) | 1.1206 | 25.14% |
| 华宝标普油气上游股票美元A | 0.1538 | 24.94% |
| 广发中证香港创新药ETF发起式联接(QDII)A | 1.3401 | 24.24% |
| 南方道琼斯美国精选C VS. 建信富时100指数(QDII)人民币A(539003) |